INTRODUCTION
BAC and PAC clones have become the preferred tool for generating transgenic animals, since they accommodate large genomic DNA fragments, are well characterized, stable and easy to propagate and purify. In recent years, efficient and reliable methods have been developed to modify their sequence in E. coli. These techniques are generally termed recombineering (homologous recombination-mediated genetic engineering) and they are based on homologous recombination between a linear double-stranded DNA cassette or synthetic oligonucleotides and a circular DNA molecule (plasmid, BACs or PACs) (1, 2) . A variety of methods and strains have been described for homologous recombination, but the most widely used methods derive the homologous recombination machinery from the bacteriophage -encoded Red system (3). The DY380 strain of E. coli is derived from DH10B and encodes a defective -prophage, in which the recombination apparatus is expressed under the control of the temperature-sensitive repressor (cI857) (3, 4) . Two further strains have been derived from DY380 in which the tetracycline resistance gene, (encoded on the bacterial genome) is substituted by either Flp (strain EL250) or Cre (strain EL350) genes (5). The Flp or Cre genes are expressed under the control of the arabinose-inducible AraC-P BAD promoter to allow further manipulation of introduced BAC/PACs. Cre DNA recombinase catalyses the recombination between two 34-bp loxP elements. The outcome (excision or inversion) depends on the relative orientation of the 2 loxP elements (6) . The loxP element contains a core spacer sequence of 8-bp flanked by two palindromic sequences each of 13-bp to which Cre binds (7) . Up to 5 mismatches from the consensus in each of the two palindromic sequences can be tolerated by Cre, without significantly reducing DNA binding (8, 9) . The core sequence is the cleavage site; its asymmetry defines the direction of the loxP site and homology in this region between two loxP sites is required for efficient recombination (10) . When recombination occurs between a mutant loxP site, which bears a deletion in the spacer region, and a wild-type loxP site, the introduction of single-and double-strand breaks in the DNA may occur (11) . On a statistical basis, the 34-bp consensus loxP site is not expected to be present in mammalian genomes, but the presence of functional recombinase recognition sites, that diverge significantly from the native loxP site, has been identified in both the human and mouse genomes (12) . These cryptic (or pseudo) loxP sites, can support Cre-mediated recombination at high efficiency when cryptic loxP sites with the same spacer region are involved in the recombination (12) . Studies have shown that Cre expression in mammalian cells causes recombination events between cryptic loxP sites resulting in gross chromosomal rearrangements in spermatids (13) and, in cultured mammalian cells, growth inhibition accompanied by DNA damage (14) . Furthermore, recombination can occur even when the spacer regions display a relatively high level of non-homology (15) . Moreover, it is generally acknowledged that some large DNAs grow slowly in Cre-containing E. coli and it has been reported that modified strains of E. coli are not ideal for receiving PACs and BACs and some BAC clones cannot be transformed into such strains for reasons that are not fully understood (16) .
Our hypothesis is that cryptic loxP sites, encoded in the mammalian genomic DNA insert, may act as substrates for Cre recombinase, expression of which may be leaky in some bacterial strains.
Here, we describe the use of a bioinformatics tool to identify such cryptic sites and experiments to test these predictions carried out on BAC/PACs.
MATERIAL AND METHODS

In silico identification of cryptic loxP sites
To automate the identification of cryptic loxP sites within a given DNA sequence a bioinformatics workflow was created using Taverna [TAVERNA] (17) . Taverna provides a workbench application that enables the construction and enactment of workflows within a graphical environment. A schematic representation of the workflow is illustrated in Figure 1 . This workflow takes a DNA sequence and searches for matches to three different patterns using Fuzznuc, which is freely available as part of the European Molecular Biology Open Software Suite (EMBOSS) [EMBOSS] (18) and is accessed via a Soaplab [SOAPLAB] web service (19) . Pattern 1 is described by the sequence ATAACTTCGT ATA (N) 8 TATACGAAGTTAT (12) and it selects for high homology in the 13-bp palindromic regions of the wild-type loxP. This pattern is augmented by a mismatch parameter that allows up to 10 mismatches to be tolerated (8, 9 ). Pattern 2 is described by the sequence ATNAC(N) 2 CNTATA (N) 8 TATANG(N) 2 GTNAT. It selects for conservation of those base pairs in the loxP site believed to be contact points for the Cre enzyme (underlined bases in the sequence ATAACTTCGTATA ATGTATGC TATACGAAGTTAT). This pattern is augmented by a mismatch parameter that allows up to 5 mismatches to be tolerated. We hypothesized that the mismatches allowed in this search could be tolerated by the Cre recombinase. Pattern 3 is described by the sequence (N) 9 TATA (N) 8 TATA(N) 9 . It ensures that the TATA motif surrounding the core 8-bp spacer region is present. This pattern is augmented by a mismatch parameter that ensures no mismatches are tolerated. The fulfilment of these three criteria defines a primary cryptic loxP site and provides a wider classification then previously proposed (12) .
A web service called FuzznucComparator was developed that compares the output from two Fuzznuc processes and outputs only those sequences present in both. When the result of the comparison contains more than one sequence, the FuzznucComparator tool performs 2 pairwise alignments of the core 8-bp spacer regions. The first alignment is calculated using the sequences in their given orientation. The second complements one sequence prior to making the alignment. The output file format consists of the result of the pairwise comparison (if any) followed by those sequences present in both input files in fuzznuc's seqtable format.
To isolate those sequences that match all three patterns two comparisons are required. First, a FuzznucComparator process is used to isolate those sequences that match patterns 1 and 2. A fileDivider process splits the output content and outputs only the fuzznuc seqtable section. Second, a FuzznucComparator process compares the output from the fileDivider process Plasmid, BAC/PAC vectors, E. coli strains and growth conditions pROSA26/Tet is a pBluescript-modified plasmid containing a tetracycline resistance gene sub-cloned between two loxP consensus sequences (pROSA26 unpublished, personal gift from Yuri Kotelevtsev, University of Edinburgh. Original source Igor Samokhvalov, RIKEN Center for Developmental Biology, Kobe Japan). This plasmid contains no AraC-P BAD promoter elements.
PAC111L11 ( EL350 and EL250 differ from DY380 in that they encode the Cre and Flp recombinase genes respectively under the control of AraC-P BAD promoter and they are not tetracycline resistant (5) .
One hundred nanograms of PAC or BAC DNA were transformed into EL350 and DY380 bacterial strains by electroporation (Easyjet Plus, Equibio; 1.75 kV, 200 ohms, 2 mF). Following selection on kanamycin/ chloramphenicol plates, a 10 À6 dilution of cells was plated on LB agar plates containing either 0.2% arabinose or 0.2% glucose and incubated overnight at 328C.
In vivo assay for Cre activity in EL350
EL350 cells were transformed with 40 ng of pROSA26/ TET plasmid DNA by electroporation and plated on LB agar containing 50 mg/ml ampicillin or 25 mg/ml tetracycline or both antibiotics. After overnight growth at 328C, colonies were counted and the ratio of tetracyclineresistant colonies to ampicillin-resistant colonies calculated as a measure of the Cre gene expression in EL350 in the un-induced state. This measure was then compared to the Cre activity after induction of the P BAD -promoter with 0.1% arabinose, according to a protocol adapted from Lee et al. (2001) (5) which is available at http:// recombineering.ncifcrf.gov/Protocol.asp. Two cell dilutions (10 À4 and 10 À6 ) were plated on Amp, Amp/Tet and Tet plates.
In vitro assay for BAC/PAC DNA nicking One microgram of BAC/PAC DNA extracted from DY380 cells was incubated with 1 or 2 ml of Cre enzyme (1000 U/ml, New England Biolabs) overnight. After the incubation, each reaction was phenol-chloroform extracted and ethanol precipitated. An aliquot of DNA was then digested with EcoRV or HindIII restriction enzymes (Promega). DNA, re-suspended in alkaline gel loading buffer (50 mM NaOH, 1 mM EDTA, 2.5% Ficoll and 0.025% bromoCresol green), was loaded on a denaturing gel as previously described (21) . Following electrophoresis, the gel was soaked in 0.25 N HCl for 6-7 min, rinsed and neutralised in 0.5 N NaOH, 1.5 M NaCl for 30 min, blotted onto a positively charged membrane and hybridized according to standard procedures with specific radiolabelled probes, generated using the Ready-To-Go DNA Labelling beads (Amersham Pharmacia Biotech). Probes P1 (for the detection of cryptic loxP site 1) P2 and P3 (to detect cryptic loxP site 2) were generated by PCR from the PAC111L11 clone, using primers c-loxP1F 5 0 -CTCAGACACTTTGGTGGG TC-3 0 and c-loxP1R 5 0 -GACTTTCAGTATGGCTGCCT AAC-3 0 for probe 1 (P1); c-loxP2F 5 0 -CAGGAGTTAG AGACCAGC-3 0 and c-loxP2R 5 0 -GCTATCTCGGCTC ACTG-3 0 for probe 2 (P2) and c-loxP3F 5 0 -GAAGGGCT GAGGTTAGGCAG-3 0 and c-loxP3R 5 0 -GAACACCTA CTGAGCTTGAG-3 0 for probe 3 (P3).
RESULTS
Mouse genome-wide distribution of cryptic loxP sites
In order to assess the distribution and frequency of cryptic loxP sites in the genome, a new bioinformatics tool (FuzznucComparator) was developed to perform a mouse genome-wide search (see materials and methods). Two stringencies were applied. Primary cryptic loxP sites were identified as sequences conforming to three patterns, which together define a primary cryptic loxP site (homology in the 13-bp palindromic sequences of the loxP consensus sequence; conservation of base pairs in the loxP site believed to be contact points for the Cre enzyme and presence of the four bases (TATA) flanking the core sequence). Figure 1 shows the workflow for the search of cryptic loxP sites. FuzznucComparator also defined secondary cryptic loxP sites, using less stringent criteria where the mismatch allowance for the three patterns is increased arbitrarily by the operator. In our hypothesis, some of these secondary sites have the potential to bind Cre and mediate DNA damage, if they are located near primary cryptic loxP sites. The NCBI m34 mouse assembly (http://www.ncbi.nlm. nih.gov/genome/seq/NCBIContigInfo.html) was split into one-megabase regions and submitted to the Fuzznuc and FuzznucComparator search for the three patterns defining a primary cryptic loxP site. The output of the search is represented in Figure 2 . The overall frequency of primary cryptic loxP sites in the mouse genome is About 10% of the spacer regions in primary cryptic loxP sites are not unique, and occur more than once.
In silico identification of cryptic loxP in PAC/BAC sequences Three BAC and PAC clones (BACN10, ASBAC and PAC111L11) were scanned for cryptic loxP sites (in addition to the consensus loxP site in the backbone of their respective vectors) to see whether their presence caused instability in Cre-expressing host cells. Both PAC111L11 and BACN10, which span the human and mouse renin locus respectively, show the presence of primary cryptic loxP sites that match all three patterns. The search returned two potential cryptic loxP sequences (c-loxP1 and c-loxP2) in PAC111L11 with 5 out of 8 bp matching in the spacer region (62.5% identity) ( Table 1) 
BACN10 is predicted to contain four primary cryptic loxP sites. Two of these are identical at 6 out of 8 bp in the spacer region and the other two match at 5; both pairs of sites show conservation in the four bases flanking the spacer region (Table 1) . A search for secondary cryptic loxP sites in the regions surrounding the primary sites returned one hit with the same characteristics outlined for the sc-loxP site in PAC111L11.
ASBAC contains 5 sequences that match the first two criteria for primary cryptic loxP sites but, when considered in pairs, none show conservation in the four bases flanking the core region (Table 1) . Since not all three criteria for cryptic loxP definition are satisfied, these sites are not predicted to be functional.
Differential growth of PAC/BAC-transformed EL350 E. coli strain compared to DY380 and EL250
To test the hypothesis that cryptic loxP sites mediate DNA damage in E. coli strains expressing Cre recombinase, PAC111L11 (depicted in Figure 3 ) was transformed into DY380 (expressing neither Cre nor Flp), EL250 (expressing Flp) and EL350 (expressing Cre) E. coli (3). Transformed cells were grown in the presence of arabinose (to induce the AraC-P BAD promoter) or glucose (to ensure catabolite repression of the promoter) (22) (23) (24) . Whilst the growth of PAC111L11-transformed DY380 and EL250 cells was similar on plates containing glucose or arabinose ( Figure 4B and C), the growth of PAC111L11-transformed EL350 cells differed on arabinose, with a similar number of colonies of much smaller size ( Figure 4A ). Statistically significant reduced colony diameter is observed on arabinose plates when comparing PAC111L1-transformed EL350 (colony diameter 0.51 AE 0.02 mm) cells to PAC111L11-transformed DY380 (colony diameter 1.69 AE 0.02 mm on arabinose, p50.001) or EL250 (colony diameter 1.44 AE 0.02 mm on arabinose, p50.01) cells. In addition, the EL350-PAC111L11 colonies formed in the presence of glucose were appreciably smaller than those formed by DY380 or EL250 transformants. The effect of glucose on PAC111L11-transformed EL350 colony size is concentration-dependent with 1% glucose resulting in the largest colonies ( Figure 5 ). Un-transformed DY380 and EL350 cells grow with the same efficiency in 0.2% arabinose-containing agar, despite the presence of one primary cryptic loxP site in the E. coli bacterial genome ( Figure 5, inset) .
EL350 cells transformed with BACN10 also gave rise to very small colonies that failed to grow or had delayed growth on arabinose (data not shown), whereas EL350 cells transformed with ASBAC showed no difference in growth rate.
In vivo assay for Cre activity in EL350
Low levels of expression from the P BAD promoter can occur in the absence of the inducer arabinose if the expression at maximum induction is very high. Leaky Cre expression from the AraC-P BAD promoter has been described for multi-copy plasmids (25) . However, in EL350 cells the AraC-P BAD -Cre gene is present in a single copy. To test if Cre was produced from the un-induced AraC-P BAD promoter in EL350, a functional test was performed, using a plasmid vector (pROSA26/ Tet) encoding a tetracycline resistance gene between two loxP consensus sequences ( Figure 6A ). The plasmid pROSA26/Tet also confers ampicillin resistance to the host. If recombination occurs between the loxP sequences, the Tet resistance gene is excised and the E. coli strain can only grow under Amp selection. This was the case when Cre expression in EL350 cells was induced with arabinose. Two cell dilutions (10 À4 and 10 À6 ) were plated on LB agar plates containing either 50 mg/ml ampicillin or 25 mg/ml tetracycline or both. Although many colonies were obtained on ampicillin, no colonies were observed on Amp/Tet or Tet plates ( Figure 6B ), even after 24 h. Following transformation with pROSA26/Tet, Tet resistant colonies were obtained in the absence of arabinose (when the AraC-P BAD promoter is not induced in EL350 cells), however, the number of colonies was reduced approximately twenty-fold ( Figure 6B ). These data show that about 95% of the colonies that are able to grow on an Amp/Tet plate have lost the tetracycline gene and are no longer able to grow under tetracycline selection (p50.01). In order to verify if all the plasmid molecules inside a single E. coli colony have undergone site-specific recombination or a few of them retain the tetracycline resistance gene, a PCR assay was performed on colonies using primer T3 and T7 ( Figure 6C) . A mixed plasmid population (excised and non-excised) is recovered from un-induced EL350. This is shown by the presence of two DNA fragments, one of 1.5 Kb (Tet retaining plasmids) and one of 0.2 Kb (Tet excised plasmids). After induction of EL350 with arabinose, the tetracycline resistance gene was found to be 100% excised. Plasmids that grow into DY380 do not show any sign of site-specific recombination and maintain the tetracycline resistance gene ( Figure 6C, right panel) .
Analysis of nicks in PAC111L11 DNA after incubation with Cre
The ability of Cre recombinase to introduce single or double-strand nicks at cryptic loxP sites was tested by incubation with PAC111L11 DNA. DNA fragments produced by the action of Cre were detected by Southern blot following either HindIII or EcoRVV restriction digest for the analysis of c-loxP1 nicks or cloxP2 nicks, respectively using a c-loxP1 specific probe (P1) or c-loxP2 specific probes (P2 and P3; Figure 7) . PAC111L11 DNA showed no evidence of nicking or cleavage at c-loxP1 following overnight incubation with Cre recombinase (Figure 7C ). Only one band of 3.5 kb, corresponding to the intact DNA, was detected by probe P1. In contrast, hybridization of probes P2 and P3 to EcoRVV-digested PAC111L11 DNA detected fragments consistent with cleavage at both c-loxP2 and sc-loxP sites ( Figure 7D and E). In the absence of Cre, the expected 6.6 kb fragment produced by EcoRVV digestion of intact PAC111L11 DNA was detected. At the higher concentration of Cre, additional fragments of 4.3 kb (with probe P2, Figure 7D ) and 0.9 kb (with probe P3, Figure 7E ) were detected.
These results suggest that the primary (c-loxP2) and the secondary (sc-loxP) c-loxP sites that map in the PAC111L11 insert are able to bind Cre recombinase enzyme and start a recombination event, which is non-productive and results in damage to the PAC DNA molecule.
The absence of the nicked 2.9 kb at the c-loxP1 site and 5.7 kb at the c-loxP2 site suggests that these cryptic loxP site are not getting paired and defectively recombined with the proper consensus loxP site that is located in the backbone of the PAC sequence.
DISCUSSION
Although little evidence has been reported, certain BAC/ PAC inserts are difficult to propagate in Cre-containing E. coli strains. It is possible this could be due to low levels of Cre promoting single strand DNA breaks or recombination through cryptic loxP sites present in the inserts. Computational analysis of the whole mouse genome has revealed an average of 1.2 primary cryptic loxP sites per Mb DNA, with few hotspots present (chromosome y has none). The new bioinformatic tool, FuzznucComparator has been made available through a Distributed Annotation System (DAS) resource to enable dynamic access to the data using http requests (i.e. a URL), with the response being returned as XML. This resource is implemented using a Dazzle [DAZZLE] server backed by an LDAS database and can be accessed at: http://wilkie226.dmed.ed.ac.uk:8080/das. Access via the DAS protocol also allows these annotations to be viewed as a track within Ensembl (Ensembl help, http:// www.ensembl.org/Homo_sapiens/helpview?se¼1;kw¼das confview, documents how to achieve this).
We have tested the power of the programme to predict functional cryptic loxP sites in the genomic insert of BAC and PAC sequences, which could potentially affect their growth in Cre recombinase expressing E. coli strains. We have identified primary and secondary cryptic loxP sites in the genomic insert of three BAC/PAC clones and shown that these are substrates for Cre recombinase in vitro. Furthermore, following transformation into EL350 cells, they demonstrate a dramatically reduced growth rate in the presence of arabinose, compared to DY380 and EL250. The poor growth is ameliorated by glucose suggesting a Cre-mediated effect on bacterial growth. We suggest that, since Cre recombinase is leaky, EL350 has a growth defect when transformed with PAC111L11.
Despite the higher conservation level of c-loxP1 and c-loxP2, our data shows that c-loxP2 and sc-loxP are involved in the single-strand nicking of PAC111L11, incubated in vitro with Cre recombinase. c-loxP2 and sc-loxP are located relatively close to each other, whereas c-loxP1 lies 70 kb away from c-loxP2. The interaction of Cre recombinase with cryptic loxP sites is likely to be weaker than with genuine loxP sites. However, proximity of two cryptic loxP sites may serve to increase the local concentration of Cre recombinase, increasing the likelihood of DNA nicking at one or both sites.
All three BAC/PAC molecules we have analysed contain a loxP consensus sequence in their respective vector backbones. However, we consider it unlikely that they mediate nicking for the following reasons: (1) they occur in most if not all BAC/PAC vectors and clearly DNA nicking and poor growth is not a problem with all BAC/PACs. (2) ASBAC also encode putative cryptic loxP sites, however, their presence did not result in slower growth in EL350 cells than EL250 or DY380 cells. We cannot exclude that in other molecules DNA damage might occur if the conditions (homology in the spacer region and location of the c-loxP site close to the end of the insert, and thus proximal to the genuine loxP site) are favourable. These data provide a functional definition of active cryptic loxP sites; more relaxed mismatches allowance in comparison to the criteria previously set (12) shows that a high degree of deviation from the loxP consensus sequence is still tolerated by Cre recombinase.
The demonstration that Cre recombinase expression is leaky in this strain supports the hypothesis that the damaged PAC DNA fails to replicate, depriving the E. coli daughter cells of the selectable marker. These findings are in accordance with data in the literature that show that mammalian genomes contain active recombinase recognition sites (12) and that growth inhibition and DNA damage can be induced by the expression of Cre recombinase in mammalian cells, E. coli and yeast (14, (26) (27) (28) . The leakiness of Cre recombinase in EL350 cells is not surprising. Studies have demonstrated that P BAD promoters are very efficient, but the levels of repression are not always zero, because they are relative to the levels of expression at maximum induction (25) .
During cleavage, Cre becomes covalently attached to the DNA through a 3 0 -phosphate. This type of covalent protein-DNA linkage is very similar to that observed with DNA topoisomerases (11, (29) (30) (31) . In the presence of cryptic loxP sites or mutant loxP sites (11), Cre protein attempts to carry out recombination, but the reaction is abortive. If the reaction progresses to the stage where nicks are introduced into the DNA, then a damaged DNA molecule is produced, which is covalently linked to a protein making it very difficult to repair by the cell repair machinery (32) .
Many lines of transgenic mice have been generated that express Cre recombinase, but there are few reports of adverse effects of this protein in vivo. The potential for DNA damage is demonstrated by the infertility of transgenic mice expressing Cre in spermatids, due to illegitimate Cre-dependent chromosome rearrangements (13) . It is possible that somatic mutations remain undetected, due to the high tolerance of mammals for somatic cell death and, in light of this study, a more detailed analysis of the phenotype of transgenic animals bearing the Cre recombinase gene may be informative.
Finally, these results suggest that the presence of cryptic loxP sites in BAC/PAC inserts can affect the efficiency of recombineering techniques if the host cells express Cre recombinase even in a leaky way. This problem is BAC/PAC dependent and does not diminish the usefulness of recombineering techniques. Nevertheless, these data propose and describe a mechanism, which explains why recombineering experiments sometimes don't give the expected results and provide a bioinformatic tool, which can alert and guide in the planning process. The use of FuzznacComparator to identify cryptic loxP sites in BAC/PAC inserts may be helpful in determining which BACs may prove to be most manipulatable with the Cre/loxP system.
